Speaker Profile
Ph.D., Chief Scientific Officer, AOA Dx
Biography
At AOA, Abby is responsible for strategic management and technical oversight of all of AOA's product offerings, spanning the product lifecycle from research to commercial manufacturing. Abby has nearly two decades of oncology diagnostics experience, including leadership roles at Roche Tissue Diagnostics (Ventana), Thrive (Exact Sciences) and PGDx (LabCorp). She has overseen RD, regulatory submissions, and product launches, including IHC-based companion diagnostics, NGS panels, and ML-enabled multi-omic assays for early cancer detection. Abby specializes in uniting science, teams, and tech to develop impactful diagnostic systems.
Talk
Lipid Profiling for Ovarian Cancer Early Detection
Ovarian cancer (OC) is diagnosed at late stages due to ineffective diagnostics. Lipids are promising cancer biomarkers, and technology has advanced to utilize them clinically. We describe our approach using lipids, proteins and machine learning to develop a diagnostic OC assay. We discovered molecular signatures that distinguish OC in symptomatic and asymptomatic populations.
Clinical Dx Showcase:
AOA Dx
AOA Dx is a biotech company revolutionizing early cancer detection for women, starting with ovarian cancer. Using multi-omics and advanced computational biology, their platform enables non-invasive diagnostics to identify cancer early, improving survival rates and patient outcomes.
Session Abstract – PMWC 2025 Silicon Valley
The PMWC 2025 Data Applications in Clinical Diagnostics Showcase will provide a 15-30 minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Neurodegenerative
